Annual Book Value
-$6.78 M
-$11.39 M-115.01%
31 December 2023
Summary:
Xeris Biopharma Holdings annual book value is currently -$6.78 million, with the most recent change of -$11.39 million (-115.01%) on 31 December 2023. During the last 3 years, it has fallen by -$40.54 million (-120.09%). XERS annual book value is now -107.12% below its all-time high of $95.23 million, reached on 31 December 2021.XERS Book Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Book Value
-$28.32 M
-$9.04 M-46.86%
30 September 2024
Summary:
Xeris Biopharma Holdings quarterly book value is currently -$28.32 million, with the most recent change of -$9.04 million (-46.86%) on 30 September 2024. Over the past year, it has dropped by -$32.19 million (-832.81%). XERS quarterly book value is now -125.90% below its all-time high of $109.34 million, reached on 30 June 2018.XERS Quarterly Book Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XERS Book Value Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -115.0% | -832.8% |
| 3 y3 years | -120.1% | -1050.9% |
| 5 y5 years | -109.0% | -164.9% |
XERS Book Value High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -107.1% | at low | -129.4% | at low |
| 5 y | 5 years | -107.1% | at low | -129.4% | at low |
| alltime | all time | -107.1% | +88.3% | -125.9% | +51.0% |
Xeris Biopharma Holdings Book Value History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$28.32 M(+46.9%) |
| June 2024 | - | -$19.29 M(+110.1%) |
| Mar 2024 | - | -$9.18 M(+35.3%) |
| Dec 2023 | -$6.78 M(-115.0%) | -$6.78 M(-275.5%) |
| Sept 2023 | - | $3.87 M(-71.7%) |
| June 2023 | - | $13.64 M(-54.6%) |
| Mar 2023 | - | $30.05 M(-33.5%) |
| Dec 2022 | $45.19 M(-52.6%) | $45.19 M(-17.9%) |
| Sept 2022 | - | $55.04 M(-25.6%) |
| June 2022 | - | $73.94 M(-23.3%) |
| Mar 2022 | - | $96.45 M(+1.3%) |
| Dec 2021 | $95.23 M | $95.23 M(-3969.6%) |
| Sept 2021 | - | -$2.46 M(-112.4%) |
| June 2021 | - | $19.89 M(-55.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $44.39 M(+31.5%) |
| Dec 2020 | $33.76 M(+133.9%) | $33.76 M(+135.5%) |
| Sept 2020 | - | $14.34 M(-41.2%) |
| June 2020 | - | $24.38 M(-9.9%) |
| Mar 2020 | - | $27.07 M(+87.5%) |
| Dec 2019 | $14.44 M(-80.9%) | $14.44 M(-66.9%) |
| Sept 2019 | - | $43.66 M(-41.6%) |
| June 2019 | - | $74.79 M(-30.2%) |
| Mar 2019 | - | $107.10 M(+42.0%) |
| Dec 2018 | $75.41 M(-230.4%) | $75.41 M(-20.7%) |
| Sept 2018 | - | $95.12 M(-13.0%) |
| June 2018 | - | $109.34 M(+232.8%) |
| Mar 2018 | - | $32.85 M(-156.8%) |
| Dec 2017 | -$57.83 M(+81.1%) | -$57.83 M |
| Dec 2016 | -$31.93 M | - |
FAQ
- What is Xeris Biopharma Holdings annual book value?
- What is the all time high annual book value for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings annual book value year-on-year change?
- What is Xeris Biopharma Holdings quarterly book value?
- What is the all time high quarterly book value for Xeris Biopharma Holdings?
- What is Xeris Biopharma Holdings quarterly book value year-on-year change?
What is Xeris Biopharma Holdings annual book value?
The current annual book value of XERS is -$6.78 M
What is the all time high annual book value for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high annual book value is $95.23 M
What is Xeris Biopharma Holdings annual book value year-on-year change?
Over the past year, XERS annual book value has changed by -$51.97 M (-115.01%)
What is Xeris Biopharma Holdings quarterly book value?
The current quarterly book value of XERS is -$28.32 M
What is the all time high quarterly book value for Xeris Biopharma Holdings?
Xeris Biopharma Holdings all-time high quarterly book value is $109.34 M
What is Xeris Biopharma Holdings quarterly book value year-on-year change?
Over the past year, XERS quarterly book value has changed by -$32.19 M (-832.81%)